Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device
Global Heart · 18.12.2024 · 19 (1)
DOI: 10.5334/gh.1377 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Global Heart, erschienen am 18.12.2024. Verfasst von Fabio Grunspun Pitta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, Laboratório Clínico, São Paulo - SP, Brazil. Hauptthemen laut MEDLINE: Troponin I, Point-of-Care Testing, Acute Coronary Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In Acute Coronary Syndrome without ST-segment elevation, the use of high-sensitivity troponins in rapid protocols is considered the gold standard for diagnostic exclusion/confirmation, in conjunction with clinical stratification. The biggest concern regarding the techniques for troponin evaluation is the time required between collection and delivery of the result.
Objective
The objective of the present study is the clinical/laboratory validation of a POCT device for TnI.
Methods
In the first phase of the study, samples from 108 patients with known troponin values High Sensitivity Automated Troponin T (TnT) assay from Roche Diagnostics were analyzed for analytical comparability between hs-cTnI of the Analyzer Atellica® vTLi and hs-cTnT Cobas®. The second phase of the study was performed with samples from 51 patients who reported to the emergency department with chest pain for a clinical prospective evaluation and correlation between the hs-cTnI assays of the Analyzer Atellica® vTLi, hs-cTnT Cobas® and Atellica IM 1300.
Results
There was a correlation between the POCT Atellica® vTLi and hs-cTnT Cobas® in the serum samples of the control group (r = 0.660, p < 0.0001). Besides, there was a correlation between the Atellica® vTLi, serum hs-cTnT Cobas®, plasma hs-cTnT Cobas®, serum Atellica IM and plasma Atellica IM 1300 platforms in the second phase (p < 0.0001 in all cases).
Conclusion
In the present study, the Siemens POCT Atellica® vTLi device showed excellent performance in laboratory validation and correlation with the high-sensitivity TnT assay in different troponin concentration ranges. Given these results, the device can be used in institutions that intend to use a POCT device for 0- and 1-hour chest pain protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Israelita Albert Einstein, Laboratório Clínico, São Paulo - SP, Brazil.
- Siemens Healthcare Diagnósticos S.A, São Paulo - SP, Brazil.
ORCID-Profile: Fabio Grunspun Pitta, Adriana Caschera Leme, Simone Rodrigues Gomes, Tarsila Perez Mota, Fernanda Vieira Paladino, José Leão de Souza Júnior, Rosemeire de Paula Braz, Thais Cristine Rodrigues Leonel Lamounier, Jéssica Buzin Gomes Ferreira, Carlos Eduardo Dos Santos Ferreira
Zitieren
APA
Pitta, F. G., Leme, A. C., Gomes, S. R., Mota, T. P., Paladino, F. V., de Souza Júnior, J. L., de Paula Braz, R., Lamounier, T. C. R. L., Ferreira, J. B. G., & Dos Santos Ferreira, C. E. (2024). Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device. Global Heart, 19(1). https://doi.org/10.5334/gh.1377
Vancouver
Pitta FG, Leme AC, Gomes SR, Mota TP, Paladino FV, de Souza Júnior JL, et al. Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device. Global Heart. 2024;19(1). doi:10.5334/gh.1377
BibTeX
@article{Pitta2024,
author = {Pitta, Fabio Grunspun and Leme, Adriana Caschera and Gomes, Simone Rodrigues and Mota, Tarsila Perez and Paladino, Fernanda Vieira and de Souza Júnior, José Leão and de Paula Braz, Rosemeire and Lamounier, Thais Cristine Rodrigues Leonel and Ferreira, Jéssica Buzin Gomes and Dos Santos Ferreira, Carlos Eduardo},
title = {Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device},
journal = {Global Heart},
year = {2024},
volume = {19},
number = {1},
doi = {10.5334/gh.1377}
}
EUVIMED